A new editorial paper titled "Neutrophil PAD4: how does it function in cancer beyond promoting NETosis?" has been published in Oncotarget.
Oct 30, 2023
0
11
A discovery by a QIMR Berghofer-led team of international scientists has potentially unlocked an entirely new approach to targeting the blood cancer acute myeloid leukemia, bringing hope to patients who are no longer responding ...
Oct 30, 2023
0
40
The unique signaling protein known as TRPM7 can stimulate and interact with an important cellular signaling hub called the AKT machinery, which is a well-known component of multiple cellular functions that drive growth and ...
Oct 26, 2023
0
0
Selenium-enriched diets may help ward off myeloid leukemia, and a new study led by researchers in Penn State's College of Agricultural Sciences has described the mechanism by which this occurs.
Oct 24, 2023
0
66
There is a clear, unmet need for tolerable treatments that can produce durable remission among patients with higher-risk myelodysplastic syndromes (HR-MDS), according to a study published online Sept. 7 in Leukemia & Lymphoma.
Oct 20, 2023
0
0
The U.S. Food and Drug Administration has proposed a ban on the use of formaldehyde in hair relaxers over concerns about its link to respiratory problems and certain cancers.
Oct 18, 2023
0
0
Prostate cancer's resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being 'pulled into' tumors, according to new research published in Nature.
Oct 17, 2023
0
55
New research has identified a novel immunotherapy for acute myeloid leukemia. The study, published in Nature Cancer, describes a T-cell receptor that recognizes a mutation shared between a subgroup of patients with the disease. ...
Oct 2, 2023
0
101
Circadian rhythms, the internal biological clocks that regulate our daily activities, are essential for maintaining health and well-being. While the role of transcription in these rhythms is well-established, a new study ...
Oct 2, 2023
0
32
Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...
Sep 30, 2023
0
21
